Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crown Bioscience announced it has joined Critical Path Institute's (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC), a collaborative initiative dedicated to advancing the validation, qualification and regulatory adoption of ...
read more
Charles River Laboratories International announced a collaboration with Arovella Therapeutics, a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS) services for cell characterization.
read more
Formycon AG and OneSource Specialty Pharma have entered a strategic manufacturing partnership to support Formycon’s biosimilar programs for global markets.
read more
Valion Bio reported a set of strategic developments around its Toll like receptor 5 (TLR5) agonist Entolimod, underscoring plans to build an integrated biodefense and immunology platform rather than a single asset program.
read more
Kindeva announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan.
read more
Porton Advanced announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for filing by the FDA's Center for Biologics Evaluation and Research (CBER), under Drug Master File (DMF) ...
read more
Axplora reported updated EcoVadis sustainability ratings for four of its European manufacturing sites, with one site achieving platinum status and others receiving gold and silver ratings.
read more
WuXi Biologics has received FDA pre license inspection (PLI) approval for its MFG8 drug substance manufacturing facility in Hebei, clearing the way for commercial supply of a potential blockbuster autoimmune therapy.
read more
Evonik announced it is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana.
read more
Matica Biotechnology is partnering with VaxDome to bring its novel antigen-agnostic antiviral-vaccine hybrid candidates into clinical trials.
read more
Mikart announced that Darrin T. Schellin has joined the company as Chief Executive Officer.
read more
Vector Science & Therapeutics has entered an exclusive licensing and manufacturing agreement with LyoGenesis Plus, a Wisconsin-based contract manufacturer specializing in lyophilization, to support production of its proprietary peptide portfolio.
read more
Arcturus Therapeutics has entered a strategic collaboration with Thermo Fisher Scientific to support late-stage development and potential commercialization of ARCT-032, an investigational mRNA therapy for cystic fibrosis.
read more
Lonza has acquired rights to Nona Biosciences’ transferrin receptor (TfR1)-based blood-brain barrier (BBB) technology and expanded its existing collaboration with the company to support development of central nervous system (CNS) therapies.
read more
The University of California, Irvine (UC Irvine) and GlyTR Therapeutics are advancing a preclinical CAR-T program targeting solid tumors, supported by adeno-associated virus (AAV) manufacturing from CDMO ProBio.
read more